Law firm Advoro has strengthened its legal advisory capabilities by appointing Raphael Wyss as a new partner in its Zurich office. Wyss, an experienced attorney with deep expertise in life sciences, healthcare, and regulatory matters,
Tags :Raphael Wyss
Novartis has completed the spin-off of Sandoz‘s generics and biosimilars business, with the result that Sandoz Group debuted as an independent, publicly traded company. Sandoz shares were successfully listed on the Swiss stock exchange,
ELANTAS, a subsidiary of the specialty German chemicals group ALTANA, entered into a share purchase agreement with the von Finck family and tender agreements with the von Roll management pursuant to which ELANTAS will acquire
